Quantitative and functional analysis of core-specific T-helper cell and CTL activities in acute and chronic hepatitis B

Liver

Volumn 18, Issue 6, 1998, Pages 405-413

  Löhr, Hanns F ^a   Krug, Sandra ^a   Herr, Wolfgang ^a   Weyer, Sandra ^a   Schlaak, Jörg ^a   Wölfel, Thomas ^a   Gerken, Guido ^a   Büschenfelde, Karl Hermann Meyer Zum ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

CTL frequencies; Cytotoxic T lymphocytes; Elispot assay; HBV nucleocapsid antigen; Hepatitis B virus; T helper cells; Viral clearance

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; HEPATITIS B CORE ANTIGEN; HLA A2 ANTIGEN; INTERLEUKIN 4; THYMIDINE; TRITIUM;

ACUTE HEPATITIS; ADULT; ARTICLE; BLOOD ANALYSIS; BONE MARROW CELL; CELL PROLIFERATION; CHRONIC HEPATITIS; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HEPATITIS B; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; STEM CELL; T LYMPHOCYTE; THERAPY;

EID: 0031794588     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1998.tb00825.x     Document Type: Article

References (30)

1. NAYERSINA R, FOWLER P, GUILHOT S, et al. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993; 150: 4659-71.
2. PENNA A, CHISARI FV, BERTOLETTI A, et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991; 174: 1565-70.
3. REHERMANN B, FOWLER P. SIDNEY J, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181: 1047-58.
4. LÖHR H F, GERKEN G. SCHLICHT H J, MEYER ZUM BÜSCHENFELDE K-H, FLEISCHER B. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J Infect Dis 1993; 168: 1133-9.
5. BARNABA V, FRANCO A, ALBERTI A, BALSANO C, BENVENUTO R, BALSANO F. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol 1989; 143: 2650-5.
6. WATERS J A, O'ROURKE S, SCHLICHT H J, THOMAS H C. Cytotoxic T cell responses in patients with chronic hepatitis B virus infection undergoing HBe antigen/antibody seroconversion. Clin Exp Immunol 1995; 102: 314-9.
7. VITIELLO A, ISHIOKA G, GREY H M, et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. Induction of a primary cytotoxic T lymphocyte response in humans. J Clin Invest 1995; 95: 341-9.
8. FERRARI C, PENNA A, BERTOLETTI A, et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990; 145: 3442-9.
9. WAKITA T, KAKUMU S, YSHIOKA K, ISHIKAWA T, ITO Y, SHINAGAWA T. Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection. Digestion 1992; 52: 26-33.
10. LOHR H F, GOERGEN B, WEBER W. GÖDDERZ, W, MEYER ZUM BÜSCHENFELDE K-H. GERKEN G. Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment. J Med Virol 1994; 44: 330-5.
11. + T cells and HBV clearance in chronic hepatitis B with and without HBe-minus HBV mutants. Hepatology 1995; 22: 61-8.
12. TSAI S L, CHEN P J, YANG P M, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J Clin Invest 1992; 89: 87-96.
13. LÖHR H F, SCHLAAK J F, GERKEN G, FLEISCHER B, DIENES H-P, MEYER ZUM BÜSCHENFELDE K-H. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994; 14: 161-6.
14. + T cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol 1995; 69: 3358-88.
15. VINGERHOETS J, MICHIELSEN P, VANHAM G, et al. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 1998; 28: 8-16.
16. BÖCHER W O, HERZOG-HAUFF S, HERR W, HEERMANN K, GERKEN G, MEYER ZUM BÜSCHENFELDE K-H, LÖHR HF. Regulation of the neutralizing anti-HBs antibody response in vitro in HBs-vaccine recipients and patients with acute or chronic hepatitis B virus infection. Clin Exp Immunol 1996; 105: 52-8.
17. + T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. J Immunol Methods 1997; 203: 141-52.
18. + memory T cells. J Exp Med 1997; 186: 859-65.
19. INOUE M, KAKUMU S, YOSKIOKA K, TSUTSUMI Y, WAKITA T, ARAO M. Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J Immunol 1989; 142: 4006-11.
20. PENNA A, DEL PRETE G, CAVALLI A, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997; 25: 1022-7.
21. DEL PRETE G F, DE CARLI M, MASTROMAURO C, et al. Purified protein derivate of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxoplasma canis expand in vitro human T cells with stable and opposite (type I T helper or type II T helper) profile of cytokine production. J Clin Invest 1991; 88: 346-52.
22. + surface phenotype and a T helper type I profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994; 152: 3074-87.
23. MILICH D R, SCHOEDEL F, PETERSON D L, JONES J E, HUGHES J L, Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur J Immunol 1995; 25: 1663-72.
24. ROSSOL S, MARINOS G, CARUCCI P, SINGER M V, WILLIAMS R, NAUMOV NV. Interleukin-12 induction of T1 cytokines is important for viral clearance in chronic hepatitis B, J Clin Invest 1997, 99: 3025-33.
25. LASARTE J-J, SAROBE P, GULLON A, PRIETO J, BORRAS-CUESTA F. Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunisation with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cell Immunol 1992; 141: 211-8.
26. BERTOLETTI A, SETTE A, CHISARI F V, et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369: 407-10.
27. REHERMANN B, PASQUINELLI C, MOSIER S M, CHISARI F V, Hepatitis B virus (HBV) sequence variation is not common in patients with chronic HBV infection. J Clin Invest 1995; 96: 1527-34.
28. DERES K, SCHILD H, WIESMÜLLER K-H, JUNG G, RAMMENSEE H-G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989; 342: 561-4.
29. ILAN Y, NAGLER A, ADLER R, TUR KASPA R, SLAVIN S, SHOUVAL D. Ablation of persistent hepatitis B virus infection by allogenic bone marrow transplantation from an HBV immune donor. Gastroenterology 1993; 104: 1818-24.
30. LAU G K, LOK A S, LIANG R H, LAI C L, CHIU E K, LAU Y L, LAM S K. Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immune transfer. Hepatology 1997; 25: 1497-1501.